RxDoctor Payments Data

Clare Moore

Nurse Practitioner · Cleveland, MSNPI 1104332089

Payments from drug & device makers

$282in general payments, 2019–2025

Across 17 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$93
  • Dexcom, Inc.$76
  • Novartis$23
  • Biohaven Pharmaceutical Holding Company Ltd.$19
  • Lilly USA, LLC$16
  • Novo Nordisk$15
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$282100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$282 in reported general payments places this provider in the 55th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$33,321
Medicare patients
104
Services billed
1,520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$45,368
FarxigaDapagliflozin Propanediol32$44,744
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$24,479
OzempicSemaglutide11$24,178
MounjaroTirzepatide14$21,280
TrulicityDulaglutide11$13,405
XareltoRivaroxaban15$11,893
LinzessLinaclotide12$9,333
Janumet XrSitagliptin Phos/Metformin Hcl12$3,216
Valsartan61$2,755
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp18$2,456
Rosuvastatin Calcium144$2,064
Ezetimibe31$1,530
Albuterol Sulfate HfaAlbuterol Sulfate55$1,436
Metoprolol Succinate93$1,323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$93$69,22363 claims
Boehringer IngelheimJardiance$14$45,36830 claims
Lilly USA, LLCMounjaro, Trulicity$16$34,68625 claims
Novo NordiskOzempic$15$24,17811 claims
AbbVieLinzess$11$9,33312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Cleveland

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →